Zuellig Pharma Executive and Leadership Team

Yan Tan, the Chief Executive Officer at Zuellig Pharma, directs the overarching strategic vision for healthcare distribution across the Asian market. Tan architects long-term growth initiatives while ensuring the company maintains high standards in pharmaceutical logistics and commercial services. By aligning corporate objectives with regional healthcare demands, the Chief Executive Officer drives operational excellence across all business units. Yan Tan fosters collaboration with the Board to secure sustainable market expansion and technological integration. This leadership role involves navigating complex regulatory environments to improve patient access to essential medicines. Through rigorous oversight of organizational performance, the Chief Executive Officer optimizes resource allocation to support the company mission. Ultimately, Tan secures the competitive position of the firm by championing innovation in healthcare delivery and maintaining strong partnerships with global pharmaceutical manufacturers throughout the diverse Asian landscape.

Evasio Barbero, the Chief Financial Officer at Zuellig Pharma, governs the fiscal health and capital allocation strategies for the organization. Barbero directs financial planning, reporting, and risk management activities to ensure long-term stability. Overseeing the financial architecture, the Chief Financial Officer monitors regional economic trends to inform investment decisions and growth strategies. Evasio Barbero collaborates with the executive team to evaluate the profitability of new commercial services and digital initiatives. This leadership role involves maintaining transparent communication with stakeholders regarding financial performance and corporate governance. By implementing robust financial controls, the Chief Financial Officer mitigates operational risks and optimizes cash flow across diverse markets. Barbero drives fiscal discipline to support the expansion of healthcare services throughout Asia. Through strategic financial oversight, the Chief Financial Officer ensures the company possesses the necessary resources to innovate and scale operations effectively in a competitive pharmaceutical landscape.

Aylie Widjaja, the Chief Operating Officer at Zuellig Pharma, manages the daily execution of supply chain and distribution networks across the region. Widjaja optimizes logistics infrastructure to ensure the seamless delivery of pharmaceutical products to healthcare providers. Overseeing regional operational workflows, the Chief Operating Officer implements efficiency protocols that reduce lead times and enhance service reliability. Aylie Widjaja coordinates with internal teams to streamline inventory management and warehouse operations. This leadership role requires constant monitoring of market fluctuations to adjust distribution strategies accordingly. By refining operational processes, the Chief Operating Officer supports the broader goal of increasing healthcare accessibility. Widjaja maintains rigorous quality control standards across all distribution centers, ensuring compliance with international safety regulations. Through proactive management of logistics assets, the Chief Operating Officer sustains the operational backbone necessary for the company to meet critical healthcare demands throughout Asia.

Yvonne Cheah, the Chief Operating Officer, Clinical Trial Support at Zuellig Pharma, directs the specialized operations required for managing complex clinical research projects. Cheah oversees the end-to-end logistics for clinical trials, ensuring the precise handling and distribution of investigational products. By coordinating with research institutions and pharmaceutical sponsors, the Chief Operating Officer, Clinical Trial Support maintains strict adherence to global clinical standards. Yvonne Cheah manages the specialized cold-chain infrastructure necessary for sensitive medical materials. This leadership role involves optimizing trial timelines and ensuring regulatory compliance across multiple jurisdictions. Through the application of rigorous operational protocols, the Chief Operating Officer, Clinical Trial Support enhances the reliability of clinical research services. Cheah drives process improvements that facilitate faster drug development cycles. By focusing on the unique requirements of clinical trials, the Chief Operating Officer, Clinical Trial Support provides essential support for medical innovation throughout the Asian region.

Luiz Enriquez, the Chief Technology Officer at Zuellig Pharma, architects the digital transformation strategy to modernize healthcare service delivery. Enriquez oversees the development of proprietary platforms that enhance data analytics, supply chain visibility, and customer engagement. By integrating advanced technology solutions, the Chief Technology Officer drives operational efficiency and supports the digital needs of pharmaceutical partners. Luiz Enriquez manages the cybersecurity framework to protect sensitive health data across all regional operations. This leadership role involves identifying emerging technologies that improve patient outcomes and streamline commercial processes. Through the implementation of scalable cloud infrastructure, the Chief Technology Officer enables the company to adapt quickly to market changes. Enriquez fosters a culture of innovation within the technical teams to ensure the firm remains at the forefront of digital healthcare. Ultimately, the Chief Technology Officer secures the technological foundation required for sustained growth and service excellence.

Avraham Raz, the Vice President COMMERCIAL EXCELLENCE and CHIEF OF STAFF at Zuellig Pharma, aligns organizational strategy with commercial execution. Raz directs initiatives that improve sales performance and market penetration for pharmaceutical services. By analyzing market data, the Vice President COMMERCIAL EXCELLENCE and CHIEF OF STAFF identifies opportunities for revenue growth and service optimization. Avraham Raz coordinates cross-functional projects to ensure the executive team remains focused on high-priority corporate objectives. This leadership role involves managing internal communications and facilitating strategic planning sessions. Through the development of commercial frameworks, the Vice President COMMERCIAL EXCELLENCE and CHIEF OF STAFF enhances the effectiveness of regional sales teams. Raz drives the implementation of best practices to ensure consistent service delivery across all markets. By bridging the gap between strategy and operations, the Vice President COMMERCIAL EXCELLENCE and CHIEF OF STAFF supports the overall mission of expanding healthcare access through commercial excellence.

Avi Raz, the Vice President Commercial Excellence and Chief of Staff, Zuellig Pharma Commercialization at Zuellig Pharma, focuses on the commercialization of specialized healthcare solutions. Raz directs the go-to-market strategies for new pharmaceutical products and services. By refining the commercialization process, the Vice President Commercial Excellence and Chief of Staff, Zuellig Pharma Commercialization ensures that innovative treatments reach patients efficiently. Avi Raz manages the integration of commercial activities with broader corporate goals to maximize market impact. This leadership role involves overseeing the performance metrics of commercial teams and adjusting tactics to meet regional demand. Through the application of data-driven insights, the Vice President Commercial Excellence and Chief of Staff, Zuellig Pharma Commercialization optimizes the product launch lifecycle. Raz fosters strong relationships with healthcare stakeholders to drive adoption of new services. By prioritizing commercial agility, the Vice President Commercial Excellence and Chief of Staff, Zuellig Pharma Commercialization supports the company growth strategy.

Pucknalin Bulakul, the Chief Operations Officer at Zuellig Pharma, manages the internal scaling and organizational efficiency of the company. Bulakul directs the optimization of administrative and operational support functions to ensure seamless business continuity. By streamlining internal processes, the Chief Operations Officer enhances the productivity of regional teams. Pucknalin Bulakul oversees the implementation of operational policies that support the company mission of improving healthcare access. This leadership role involves coordinating with other C-suite members to ensure that operational capacity aligns with strategic growth targets. Through the management of internal resources, the Chief Operations Officer drives cost-effectiveness and operational agility. Bulakul monitors performance indicators to identify areas for continuous improvement within the organization. By focusing on the internal operational framework, the Chief Operations Officer provides the necessary stability for the company to execute its complex healthcare services across the diverse Asian market landscape.